Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure

Stopped The study has been terminated due to changed clinical conditions and too few patients available

Conditions

• Corona Virus Disease

Interventions

• DRUG: RoActemra iv
• DRUG: RoActemra sc
• DRUG: Kevzara sc
• OTHER: Standard medical care

Sponsor

Marius Henriksen